IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kenyon, B. M.
Right arrow Articles by D'Amato, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kenyon, B. M.
Right arrow Articles by D'Amato, R. J.

Investigative Ophthalmology & Visual Science, Vol 37, 1625-1632, Copyright © 1996 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

A model of angiogenesis in the mouse cornea

BM Kenyon, EE Voest, CC Chen, E Flynn, J Folkman and RJ D'Amato
Department of Surgery, Children's Hospital, Boston, Massachusetts 02115, USA.

PURPOSE: The study of angiogenesis depends on reliable and reproducible models for the stimulation of a neovascular response. The purpose of this research was to develop such a model of angiogenesis in the mouse cornea. METHODS: Uniformly sized Hydron pellets containing either basic fibroblast growth factor (bFGF) or vascular endothelial growth factor (VEGF) and sucralfate were prepared and implanted into the stroma mouse cornea adjacent to the temporal limbus. RESULTS: Neovascularization of the corneal stroma began on day 3 and was sustained through day 8. The bFGF-induced neovascularization was consistent and dose dependent in C57B1/6, as well as in severe combined immune deficient, beige natural killer cell-deficient, and nude mouse strains. Biomicroscopic and histologic examination of bFGF- and VEGF-induced angiogenesis was notable for the absence of corneal edema or substantial inflammation. CONCLUSIONS: This noninflammatory model of corneal neovascularization is especially advantageous because it is reproducible, economical, and facilitates investigation of angiogenesis in various murine tumor models as well as in genetically defined murine strains.


This article has been cited by other articles:


Home page
DevelopmentHome page
U. Tigges, E. G. Hyer, J. Scharf, and W. B. Stallcup
FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages
Development, February 1, 2008; 135(3): 523 - 532.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Schwartz, J. George, J. Ben-Shoshan, G. Luboshits, I. Avni, H. Levkovitch-Verbin, H. Ziv, M. Rosner, and A. Barak
Drug Modification of Angiogenesis in a Rat Cornea Model
Invest. Ophthalmol. Vis. Sci., January 1, 2008; 49(1): 250 - 254.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
J.-J. You, C.-H. Yang, J.-S. Huang, M.-S. Chen, and C.-M. Yang
Fractalkine, a CX3C Chemokine, as a Mediator of Ocular Angiogenesis
Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5290 - 5298.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. S. Rogers, K. A. Christensen, A. E. Birsner, S. M. Short, D. J. Wigelsworth, R. J. Collier, and R. J. D'Amato
Mutant Anthrax Toxin B Moiety (Protective Antigen) Inhibits Angiogenesis and Tumor Growth
Cancer Res., October 15, 2007; 67(20): 9980 - 9985.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
R. Kumar, V. B. Knick, S. K. Rudolph, J. H. Johnson, R. M. Crosby, M.-C. Crouthamel, T. M. Hopper, C. G. Miller, L. E. Harrington, J. A. Onori, et al.
Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity
Mol. Cancer Ther., July 1, 2007; 6(7): 2012 - 2021.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Umans, L. Cox, M. Tjwa, V. Bito, L. Vermeire, K. Laperre, K. Sipido, L. Moons, D. Huylebroeck, and A. Zwijsen
Inactivation of Smad5 in Endothelial Cells and Smooth Muscle Cells Demonstrates that Smad5 Is Required for Cardiac Homeostasis
Am. J. Pathol., May 1, 2007; 170(5): 1460 - 1472.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Udagawa, A. E. Birsner, M. Wood, and R. J. D'Amato
Chronic Suppression of Angiogenesis following Radiation Exposure Is Independent of Hematopoietic Reconstitution
Cancer Res., March 1, 2007; 67(5): 2040 - 2045.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
Y. Nishiwaki, M. Yoshida, H. Iwaguro, H. Masuda, N. Nitta, T. Asahara, and M. Isobe
Endothelial E-Selectin Potentiates Neovascularization via Endothelial Progenitor Cell-Dependent and -Independent Mechanisms
Arterioscler. Thromb. Vasc. Biol., March 1, 2007; 27(3): 512 - 518.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Takeda, A. R. Kazarov, C. E. Butterfield, B. D. Hopkins, L. E. Benjamin, A. Kaipainen, and M. E. Hemler
Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro
Blood, February 15, 2007; 109(4): 1524 - 1532.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
T. Kojima, J.-H. Chang, and D. T. Azar
Proangiogenic Role of ephrinB1/EphB1 in Basic Fibroblast Growth Factor-Induced Corneal Angiogenesis
Am. J. Pathol., February 1, 2007; 170(2): 764 - 773.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Cursiefen, L. Chen, M. Saint-Geniez, P. Hamrah, Y. Jin, S. Rashid, B. Pytowski, K. Persaud, Y. Wu, J. W. Streilein, et al.
Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision
PNAS, July 25, 2006; 103(30): 11405 - 11410.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Dell, S. Peters, P. Muther, N. Kociok, and A. M. Joussen
The Role of PDGF Receptor Inhibitors and PI3-Kinase Signaling in the Pathogenesis of Corneal Neovascularization
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1928 - 1937.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Kertesz, V. Krasnoperov, R. Reddy, L. Leshanski, S. R. Kumar, S. Zozulya, and P. S. Gill
The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth
Blood, March 15, 2006; 107(6): 2330 - 2338.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
E. Ueda, U. Ozerdem, Y.-H. Chen, M. Yao, K. T. Huang, H. Sun, M. Martins-Green, P. Bartolini, and A. M Walker
A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone.
Endocr. Relat. Cancer, March 1, 2006; 13(1): 95 - 111.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
T Oshima, K-H Sonoda, C Tsutsumi-Miyahara, H Qiao, T Hisatomi, S Nakao, S Hamano, K Egashira, I F Charo, and T Ishibashi
Analysis of corneal inflammation induced by cauterisation in CCR2 and MCP-1 knockout mice
Br. J. Ophthalmol., February 1, 2006; 90(2): 218 - 222.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Kisucka, C. E. Butterfield, D. G. Duda, S. C. Eichenberger, S. Saffaripour, J. Ware, Z. M. Ruggeri, R. K. Jain, J. Folkman, and D. D. Wagner
Platelets and platelet adhesion support angiogenesis while preventing excessive hemorrhage
PNAS, January 24, 2006; 103(4): 855 - 860.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. LaMontagne, A. Littlewood-Evans, C. Schnell, T. O'Reilly, L. Wyder, T. Sanchez, B. Probst, J. Butler, A. Wood, G. Liau, et al.
Antagonism of Sphingosine-1-Phosphate Receptors by FTY720 Inhibits Angiogenesis and Tumor Vascularization
Cancer Res., January 1, 2006; 66(1): 221 - 231.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Z. Zhang, J.-x. Ma, G. Gao, C. Li, L. Luo, M. Zhang, W. Yang, A. Jiang, W. Kuang, L. Xu, et al.
Plasminogen Kringle 5 Inhibits Alkali-Burn-Induced Corneal Neovascularization
Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4062 - 4071.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
U. Ozerdem, K. Alitalo, P. Salven, and A. Li
Contribution of Bone Marrow-Derived Pericyte Precursor Cells to Corneal Vasculogenesis
Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3502 - 3506.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. S. Biswas, K. Banerjee, B. Kim, P. R. Kinchington, and B. T. Rouse
Role of Inflammatory Cytokine-Induced Cycloxygenase 2 in the Ocular Immunopathologic Disease Herpetic Stromal Keratitis
J. Virol., August 15, 2005; 79(16): 10589 - 10600.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Filleur, K. Volz, T. Nelius, Y. Mirochnik, H. Huang, T. A. Zaichuk, M. S. Aymerich, S. P. Becerra, R. Yap, D. Veliceasa, et al.
Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer
Cancer Res., June 15, 2005; 65(12): 5144 - 5152.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Morisada, Y. Oike, Y. Yamada, T. Urano, M. Akao, Y. Kubota, H. Maekawa, Y. Kimura, M. Ohmura, T. Miyamoto, et al.
Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation
Blood, June 15, 2005; 105(12): 4649 - 4656.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S.-i. Hayashi, T. Asahara, H. Masuda, J. M. Isner, and D. W. Losordo
Functional Ephrin-B2 Expression for Promotive Interaction Between Arterial and Venous Vessels in Postnatal Neovascularization
Circulation, May 3, 2005; 111(17): 2210 - 2218.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C.-S. Shi, G.-Y. Shi, Y.-S. Chang, H.-S. Han, C.-H. Kuo, C. Liu, H.-C. Huang, Y.-J. Chang, P.-S. Chen, and H.-L. Wu
Evidence of Human Thrombomodulin Domain as a Novel Angiogenic Factor
Circulation, April 5, 2005; 111(13): 1627 - 1636.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Hirakawa, S. Fujii, K. Kajiya, K. Yano, and M. Detmar
Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage
Blood, March 15, 2005; 105(6): 2392 - 2399.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Chen, M. Guo, D. Wygle, P. A. Edwards, J. R. Falck, R. J. Roman, and A. G. Scicli
Inhibitors of Cytochrome P450 4A Suppress Angiogenic Responses
Am. J. Pathol., February 1, 2005; 166(2): 615 - 624.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
B. Kim, Q. Tang, P. S. Biswas, J. Xu, R. M. Schiffelers, F. Y. Xie, A. M. Ansari, P. V. Scaria, M. C. Woodle, P. Lu, et al.
Inhibition of Ocular Angiogenesis by siRNA Targeting Vascular Endothelial Growth Factor Pathway Genes: Therapeutic Strategy for Herpetic Stromal Keratitis
Am. J. Pathol., December 1, 2004; 165(6): 2177 - 2185.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. W. Park, D. Crouse, M. Lee, S. K. Karnik, L. K. Sorensen, K. J. Murphy, C. J. Kuo, and D. Y. Li
The axonal attractant Netrin-1 is an angiogenic factor
PNAS, November 16, 2004; 101(46): 16210 - 16215.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
H. Huang, S. C. Campbell, D. F. Bedford, T. Nelius, D. Veliceasa, E. H. Shroff, J. Henkin, A. Schneider, N. Bouck, and O. V. Volpert
Peroxisome Proliferator-Activated Receptor {gamma} Ligands Improve the Antitumor Efficacy of Thrombospondin Peptide ABT510
Mol. Cancer Res., October 1, 2004; 2(10): 541 - 550.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
X. Ma, P. Ottino, H. E. P. Bazan, and N. G. Bazan
Platelet-Activating Factor (PAF) Induces Corneal Neovascularization and Upregulates VEGF Expression in Endothelial Cells
Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 2915 - 2921.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. K. Chang, G. Garcia-Cardena, F. Farnebo, M. Fannon, E. J. Chen, C. Butterfield, M. A. Moses, R. C. Mulligan, J. Folkman, and A. Kaipainen
Dose-dependent response of FGF-2 for lymphangiogenesis
PNAS, August 10, 2004; 101(32): 11658 - 11663.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. S. ROGERS, R. M. ROHAN, A. E. BIRSNER, and R. J. D'AMATO
Genetic loci that control the angiogenic response to basic fibroblast growth factor
FASEB J, July 1, 2004; 18(10): 1050 - 1059.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Yu, K. S. Moulton, M. K. Khan, S. Vineberg, E. Boye, V. M. Davis, P. E. O'Donnell, J. Bischoff, and D. S. Milstone
E-selectin is required for the antiangiogenic activity of endostatin
PNAS, May 25, 2004; 101(21): 8005 - 8010.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Usui, S. Ishida, K. Yamashiro, Y. Kaji, V. Poulaki, J. Moore, T. Moore, S. Amano, Y. Horikawa, D. Dartt, et al.
VEGF164(165) as the Pathological Isoform: Differential Leukocyte and Endothelial Responses through VEGFR1 and VEGFR2
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 368 - 374.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
C. K. Chan, L. N. Pham, C. Chinn, C. Spee, S. J. Ryan, R. J. Akhurst, and D. R. Hinton
Mouse Strain-Dependent Heterogeneity of Resting Limbal Vasculature
Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 441 - 447.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Wasmuth, D. Bauer, Y. Yang, K.-P. Steuhl, and A. Heiligenhaus
Topical Treatment with Antisense Oligonucleotides Targeting Tumor Necrosis Factor-{alpha} in Herpetic Stromal Keratitis
Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5228 - 5234.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. S. Beebe, J. P. Jani, E. Knauth, P. Goodwin, C. Higdon, A. M. Rossi, E. Emerson, M. Finkelstein, E. Floyd, S. Harriman, et al.
Pharmacological Characterization of CP-547,632, a Novel Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for Cancer Therapy
Cancer Res., November 1, 2003; 63(21): 7301 - 7309.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Ito, Y. Oike, K. Yasunaga, K. Hamada, K. Miyata, S.-i. Matsumoto, S. Sugano, H. Tanihara, Y. Masuho, and T. Suda
Inhibition of Angiogenesis and Vascular Leakiness by Angiopoietin-Related Protein 4
Cancer Res., October 15, 2003; 63(20): 6651 - 6657.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
H. Zheng, C. Wasylyk, A. Ayadi, J. Abecassis, J. A Schalken, H. Rogatsch, N. Wernert, S.-M. Maira, M.-C. Multon, and B. Wasylyk
The transcription factor Net regulates the angiogenic switch
Genes & Dev., September 15, 2003; 17(18): 2283 - 2297.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Licht, L. Tsirulnikov, H. Reuveni, T. Yarnitzky, and S. A. Ben-Sasson
Induction of pro-angiogenic signaling by a synthetic peptide derived from the second intracellular loop of S1P3 (EDG3)
Blood, September 15, 2003; 102(6): 2099 - 2107.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. Patel, L. Sun, D. Moshinsky, H. Chen, K. M. Leahy, P. Le, K. G. Moss, X. Wang, A. Rice, D. Tam, et al.
A Selective and Oral Small Molecule Inhibitor of Vascular Epithelial Growth Factor Receptor (VEGFR)-2 and VEGFR-1 Inhibits Neovascularization and Vascular Permeability
J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 838 - 845.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. E. Rakoczy, M. Brankov, A. Fonceca, T. Zaknich, B. C. Rae, and C.-M. Lai
Enhanced Recombinant Adeno-Associated Virus-Mediated Vascular Endothelial Growth Factor Expression in the Adult Mouse Retina: A Potential Model for Diabetic Retinopathy
Diabetes, March 1, 2003; 52(3): 857 - 863.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Yamada, Y. Oike, H. Ogawa, Y. Ito, H. Fujisawa, T. Suda, and N. Takakura
Neuropilin-1 on hematopoietic cells as a source of vascular development
Blood, March 1, 2003; 101(5): 1801 - 1809.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
B. K. Ambati, A. Anand, A. M. Joussen, W. A. Kuziel, A. P. Adamis, and J. Ambati
Sustained Inhibition of Corneal Neovascularization by Genetic Ablation of CCR5
Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 590 - 593.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. M. Stuart, F. Pan, S. Plambeck, and T. A. Ferguson
FasL-Fas Interactions Regulate Neovascularization in the Cornea
Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 93 - 98.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. Auerbach, R. Lewis, B. Shinners, L. Kubai, and N. Akhtar
Angiogenesis Assays: A Critical Overview
Clin. Chem., January 1, 2003; 49(1): 32 - 40.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Ophthalmol.Home page
C Cursiefen, C Hofmann-Rummelt, M Kuchle, and U Schlotzer-Schrehardt
Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation
Br. J. Ophthalmol., January 1, 2003; 87(1): 101 - 106.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
L. CHANG, A. KAIPAINEN, and J. FOLKMAN
Lymphangiogenesis New Mechanisms
Ann. N.Y. Acad. Sci., December 1, 2002; 979(1): 111 - 119.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. Cheng, D. M. Brantley, H. Liu, Q. Lin, M. Enriquez, N. Gale, G. Yancopoulos, D. P. Cerretti, T. O. Daniel, and J. Chen
Blockade of EphA Receptor Tyrosine Kinase Activation Inhibits Vascular Endothelial Cell Growth Factor-Induced Angiogenesis
Mol. Cancer Res., November 1, 2002; 1(1): 2 - 11.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
R. CAO, E. BRAKENHIELM, X. LI, K. PIETRAS, J. WIDENFALK, A. OSTMAN, U. ERIKSSON, and Y. CAO
Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-{alpha}{alpha} and -{alpha}{beta} receptors
FASEB J, October 1, 2002; 16(12): 1575 - 1583.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Corada, L. Zanetta, F. Orsenigo, F. Breviario, M. G. Lampugnani, S. Bernasconi, F. Liao, D. J. Hicklin, P. Bohlen, and E. Dejana
A monoclonal antibody to vascular endothelial-cadherin inhibits tumor angiogenesis without side effects on endothelial permeability
Blood, July 18, 2002; 100(3): 905 - 911.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. P. Claffey
Molecular Profiling of Angiogenic Markers : A Step Towards Interpretive Analysis of a Complex Biological Function
Am. J. Pathol., July 1, 2002; 161(1): 7 - 11.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Zheng, D. M. Klinman, M. Gierynska, and B. T. Rouse
DNA containing CpG motifs induces angiogenesis
PNAS, June 25, 2002; 99(13): 8944 - 8949.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H. Zhang, C. Li, and P. C. Baciu
Expression of Integrins and MMPs during Alkaline-Burn-Induced Corneal Angiogenesis
Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 955 - 962.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. Lee, M. Zheng, S. Deshpande, S. K. Eo, T. A. Hamilton, and B. T. Rouse
IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis
J. Leukoc. Biol., March 1, 2002; 71(3): 469 - 476.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Thyboll, J. Kortesmaa, R. Cao, R. Soininen, L. Wang, A. Iivanainen, L. Sorokin, M. Risling, Y. Cao, and K. Tryggvason
Deletion of the Laminin {alpha}4 Chain Leads to Impaired Microvessel Maturation
Mol. Cell. Biol., February 15, 2002; 22(4): 1194 - 1202.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
U. Huynh-Do, C. Vindis, H. Liu, D. P. Cerretti, J. T. McGrew, M. Enriquez, J. Chen, and T. O. Daniel
Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis
J. Cell Sci., January 8, 2002; 115(15): 3073 - 3081.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Du, J. Luan, H. Liu, T. O. Daniel, S. Peiper, T. S. Chen, Y. Yu, L. W. Horton, L. B. Nanney, R. M. Strieter, et al.
Potential role for Duffy antigen chemokine-binding protein in angiogenesis and maintenance of homeostasis in response to stress
J. Leukoc. Biol., January 1, 2002; 71(1): 141 - 153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Zheng, M. A. Schwarz, S. Lee, U. Kumaraguru, and B. T. Rouse
Control of Stromal Keratitis by Inhibition of Neovascularization
Am. J. Pathol., September 1, 2001; 159(3): 1021 - 1029.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. U. Stechschulte, A. M. Joussen, H. A. von Recum, V. Poulaki, Y. Moromizato, J. Yuan, R. J. D'Amato, C. Kuo, and A. P. Adamis
Rapid Ocular Angiogenic Control via Naked DNA Delivery to Cornea
Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 1975 - 1979.
[Abstract] [Full Text] [PDF]